Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
143210.KS Stock Summary
In the News
143210.KS Financial details
Company Rating
Sell
Market Cap
57.07B
Income
-32.17B
Revenue
749.5B
Book val./share
12820.91
Cash/share
1811.59
Dividend
-
Dividend %
-
Employees
853
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-2.52
Forward P/E
-
PEG
0.42
P/S
0.09
P/B
0.22
P/C
1.52
P/FCF
1.94
Quick Ratio
-
Current Ratio
0.64
Debt / Equity
1.87
LT Debt / Equity
0.11
-
-
EPS (TTM)
-1.47K
EPS next Y
-
EPS next Q
-
EPS this Y
-58.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.94%
Revenue Q/Q
-2.9%
EPS Q/Q
-0.82%
-
-
-
-
SMA20
3.08%
SMA50
-3.23%
SMA100
-6.16%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-10%
ROC
-0.06%
Gross Margin
8%
Oper. Margin
-3%
Profit Margin
-3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2540.0-3530.0
52W High
-22.1%
52W Low
+8.27%
RSI
55.92
Rel Volume
0.37
Avg Volume
25.7K
Volume
9.42K
Perf Week
1.66%
Perf Month
3.97%
Perf Quarter
-9.98%
Perf Half Y
-12.14%
-
-
-
-
Beta
0.733
-
-
Volatility
30.76%, 50.18%
Prev Close
0%
Price
2750
Change
1.48%
143210.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 28.75K | 26.66K | 26.17K | 36.23K | 34.88K | |
Net income per share | 319.63 | -380.97 | -2.98K | -3.62K | -1.5K | |
Operating cash flow per share | 1.82K | -246.61 | -4.14K | 112.94 | 2.67K | |
Free cash flow per share | -3.67K | -1.15K | -5.93K | -2.25K | 1.04K | |
Cash per share | 3.87K | 3.3K | 2.63K | 1.65K | 1.85K | |
Book value per share | 15.07K | 14.63K | 12.2K | 9.05K | 13.06K | |
Tangible book value per share | 14.45K | 14.02K | 11.56K | 8.43K | 12.46K | |
Share holders equity per share | 15.07K | 14.63K | 12.2K | 9.05K | 13.06K | |
Interest debt per share | 18.7K | 18.53K | 24.1K | 25.57K | 25.88K | |
Market cap | 146.93B | 179.15B | 107.3B | 68.63B | 64.45B | |
Enterprise value | 466.33B | 514.21B | 567.34B | 577.65B | 565.45B | |
P/E ratio | 21.4 | -21.89 | -1.68 | -0.88 | -2 | |
Price to sales ratio | 0.24 | 0.31 | 0.19 | 0.09 | 0.09 | |
POCF ratio | 3.75 | -33.82 | -1.21 | 28.29 | 1.12 | |
PFCF ratio | -1.86 | -7.22 | -0.84 | -1.42 | 2.88 | |
P/B Ratio | 0.45 | 0.57 | 0.41 | 0.35 | 0.23 | |
PTB ratio | 0.45 | 0.57 | 0.41 | 0.35 | 0.23 | |
EV to sales | 0.75 | 0.9 | 1.01 | 0.74 | 0.75 | |
Enterprise value over EBITDA | 9.53 | 12.29 | -18.37 | -12.44 | 19.69 | |
EV to operating cash flow | 11.9 | -97.07 | -6.37 | 238.1 | 9.86 | |
EV to free cash flow | -5.92 | -20.74 | -4.45 | -11.94 | 25.25 | |
Earnings yield | 0.05 | -0.05 | -0.6 | -1.13 | -0.5 | |
Free cash flow yield | -0.54 | -0.14 | -1.19 | -0.7 | 0.35 | |
Debt to equity | 1.21 | 1.25 | 1.95 | 2.75 | 1.87 | |
Debt to assets | 0.46 | 0.46 | 0.57 | 0.62 | 0.52 | |
Net debt to EBITDA | 6.52 | 8 | -14.9 | -10.96 | 17.44 | |
Current ratio | 1.07 | 0.95 | 0.81 | 0.62 | 0.61 | |
Interest coverage | 2.17 | 0.4 | -6.38 | -4.7 | -0.73 | |
Income quality | 5.55 | 0.65 | 1.39 | -0.03 | -1.78 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.14 | -0.26 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0 | 0 | 0 | 0.01 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | -3.01 | 3.68 | 0.43 | -20.94 | -0.61 | |
Capex to revenue | -0.19 | -0.03 | -0.07 | -0.07 | -0.05 | |
Capex to depreciation | -3.62 | -0.5 | -0.99 | -1.35 | -0.69 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.41K | 11.2K | 28.58K | 27.16K | 20.98K | |
ROIC | 0.02 | 0 | -0.06 | -0.08 | -0.03 | |
Return on tangible assets | 0.01 | -0.01 | -0.07 | -0.09 | -0.03 | |
Graham Net | -13.3K | -14.15K | -17.63K | -20.54K | -22.49K | |
Working capital | 21.83B | -18.02B | -95.61B | -222.74B | -252.67B | |
Tangible asset value | 310.45B | 301.07B | 248.37B | 181.08B | 267.8B | |
Net current asset value | -182.37B | -196.16B | -229.09B | -306.01B | -329.21B | |
Invested capital | 1.21 | 1.25 | 1.95 | 2.75 | 1.87 | |
Average receivables | 108.85B | 101.97B | 95.09B | 104.42B | 115.88B | |
Average payables | 17.36B | 18.01B | 16.87B | 22.73B | 42.87B | |
Average inventory | 153.81B | 159.46B | 209.58B | 232.46B | 218.61B | |
Days sales outstanding | 65.13 | 59.74 | 62.62 | 52.71 | 58.14 | |
Days payables outstanding | 12.8 | 12.04 | 11.07 | 14.29 | 29.48 | |
Days of inventory on hand | 102.61 | 117.61 | 168.16 | 105.61 | 115.83 | |
Receivables turnover | 5.6 | 6.11 | 5.83 | 6.93 | 6.28 | |
Payables turnover | 28.51 | 30.32 | 32.96 | 25.55 | 12.38 | |
Inventory turnover | 3.56 | 3.1 | 2.17 | 3.46 | 3.15 | |
ROE | 0.02 | -0.03 | -0.24 | -0.4 | -0.11 | |
Capex per share | -5.49K | -907.82 | -1.79K | -2.36K | -1.63K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.83K | 8.81K | 9.01K | 8.34K | 8.09K | |
Net income per share | -506.28 | 455.9 | -359.23 | -786.42 | -779.98 | |
Operating cash flow per share | 435.93 | 269.37 | 578.44 | 453.36 | 1.32K | |
Free cash flow per share | -159.35 | -77.53 | 223.67 | -47.78 | 924.52 | |
Cash per share | 1.62K | 1.73K | 1.74K | 2.17K | 1.81K | |
Book value per share | 8.89K | 9.52K | 14.36K | 13.54K | 12.82K | |
Tangible book value per share | 8.28K | 8.9K | 13.82K | 13.04K | 12.23K | |
Share holders equity per share | 8.89K | 9.52K | 14.36K | 13.54K | 12.82K | |
Interest debt per share | 23.42K | 24.41K | 24.91K | 26.27K | 24.28K | |
Market cap | 69.91B | 62.8B | 72.21B | 71.13B | 65.68B | |
Enterprise value | 578.93B | 584.69B | 575.12B | 590.85B | 566.68B | |
P/E ratio | -1.58 | 1.57 | -2.3 | -1.03 | -0.96 | |
Price to sales ratio | 0.36 | 0.33 | 0.37 | 0.39 | 0.37 | |
POCF ratio | 7.33 | 10.65 | 5.71 | 7.17 | 2.27 | |
PFCF ratio | -20.05 | -37.02 | 14.75 | -68.02 | 3.24 | |
P/B Ratio | 0.36 | 0.3 | 0.23 | 0.24 | 0.23 | |
PTB ratio | 0.36 | 0.3 | 0.23 | 0.24 | 0.23 | |
EV to sales | 3 | 3.03 | 2.92 | 3.24 | 3.2 | |
Enterprise value over EBITDA | -26.08 | 49.68 | 31.33 | 38.78 | -117.08 | |
EV to operating cash flow | 60.69 | 99.2 | 45.44 | 59.55 | 19.61 | |
EV to free cash flow | -166.04 | -344.65 | 117.51 | -565.04 | 28 | |
Earnings yield | -0.16 | 0.16 | -0.11 | -0.24 | -0.26 | |
Free cash flow yield | -0.05 | -0.03 | 0.07 | -0.01 | 0.31 | |
Debt to equity | 2.75 | 2.63 | 1.7 | 1.89 | 1.87 | |
Debt to assets | 0.62 | 0.62 | 0.53 | 0.55 | 0.52 | |
Net debt to EBITDA | -22.93 | 44.35 | 27.39 | 34.11 | -103.51 | |
Current ratio | 0.62 | 0.64 | 0.65 | 0.64 | 0.61 | |
Interest coverage | 0.96 | -0.02 | 0.08 | -0.1 | -3.68 | |
Income quality | -0.86 | 0.61 | -1.57 | -0.6 | -1.69 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.09 | 0.09 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -1.37 | -1.29 | -0.61 | -1.11 | -0.3 | |
Capex to revenue | -0.07 | -0.04 | -0.04 | -0.06 | -0.05 | |
Capex to depreciation | -1.33 | -0.66 | -0.69 | -0.96 | -0.52 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.06K | 9.88K | 10.77K | 15.48K | 15K | |
ROIC | -0.04 | 0 | 0 | 0 | -0.03 | |
Return on tangible assets | -0.01 | 0.01 | -0.01 | -0.02 | -0.02 | |
Graham Net | -20.16K | -20.25K | -20.59K | -21.41K | -22.07K | |
Working capital | -222.74B | -204.95B | -204.67B | -226.21B | -252.67B | |
Tangible asset value | 181.08B | 194.69B | 302.5B | 285.29B | 267.8B | |
Net current asset value | -306.01B | -304.57B | -308.86B | -317.48B | -329.21B | |
Invested capital | 2.75 | 2.63 | 1.7 | 1.89 | 1.87 | |
Average receivables | 123.07B | 107.63B | 114.84B | 127.47B | 123.77B | |
Average payables | 35.23B | 34.58B | 41.24B | 46.07B | 53.34B | |
Average inventory | 230.63B | 219.75B | 222.5B | 217.69B | 219.53B | |
Days sales outstanding | 52.34 | 48.05 | 57.9 | 63.2 | 60.62 | |
Days payables outstanding | 13.82 | 20.9 | 21.29 | 26.84 | 27.94 | |
Days of inventory on hand | 102.17 | 117.18 | 110.55 | 116.15 | 109.8 | |
Receivables turnover | 1.72 | 1.87 | 1.55 | 1.42 | 1.48 | |
Payables turnover | 6.51 | 4.31 | 4.23 | 3.35 | 3.22 | |
Inventory turnover | 0.88 | 0.77 | 0.81 | 0.77 | 0.82 | |
ROE | -0.06 | 0.05 | -0.03 | -0.06 | -0.06 | |
Capex per share | -595.28 | -346.9 | -354.76 | -501.14 | -395.06 |
143210.KS Frequently Asked Questions
What is Hands Corporation Ltd. stock symbol ?
Hands Corporation Ltd. is a KR stock and trading under the symbol 143210.KS
What is Hands Corporation Ltd. stock quote today ?
Hands Corporation Ltd. stock price is $2750 today.
Is Hands Corporation Ltd. stock public?
Yes, Hands Corporation Ltd. is a publicly traded company.